900 related articles for article (PubMed ID: 15755876)
1. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
2. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB inhibits transcription of the H(+)-K(+)-ATPase alpha(2)-subunit gene: role of histone deacetylases.
Zhang W; Kone BC
Am J Physiol Renal Physiol; 2002 Nov; 283(5):F904-11. PubMed ID: 12372765
[TBL] [Abstract][Full Text] [Related]
4. The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells.
Katsura T; Iwai S; Ota Y; Shimizu H; Ikuta K; Yura Y
Cancer Gene Ther; 2009 Mar; 16(3):237-45. PubMed ID: 18949013
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-kappaB and histone deacetylase 1 in ventricular myocytes.
Shaw J; Zhang T; Rzeszutek M; Yurkova N; Baetz D; Davie JR; Kirshenbaum LA
Circ Res; 2006 Dec; 99(12):1347-54. PubMed ID: 17082476
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
[TBL] [Abstract][Full Text] [Related]
7. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
8. [NF-kappaB modulates activation of the BMP-2 gene by trichostatin A].
Li X; Bai XZ
Mol Biol (Mosk); 2008; 42(6):990-6. PubMed ID: 19140318
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
Mulholland NM; Soeth E; Smith CL
Oncogene; 2003 Jul; 22(31):4807-18. PubMed ID: 12894222
[TBL] [Abstract][Full Text] [Related]
11. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappaB pathway in breast cancer.
Chavey C; Mühlbauer M; Bossard C; Freund A; Durand S; Jorgensen C; Jobin C; Lazennec G
Mol Pharmacol; 2008 Nov; 74(5):1359-66. PubMed ID: 18669446
[TBL] [Abstract][Full Text] [Related]
14. p52-Bcl3 complex promotes cyclin D1 expression in BEAS-2B cells in response to low concentration arsenite.
Wang F; Shi Y; Yadav S; Wang H
Toxicology; 2010 Jun; 273(1-3):12-8. PubMed ID: 20420878
[TBL] [Abstract][Full Text] [Related]
15. Modulation of complement component (C3 and factor B) biosynthesis by a histone deacetylase inhibitor in human intestinal epithelial cells.
Andoh A; Fujiyama Y; Shimada M; Bamba T
Int J Mol Med; 2000 Jul; 6(1):51-4. PubMed ID: 10851266
[TBL] [Abstract][Full Text] [Related]
16. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
Lu X; Farmer P; Rubin J; Nanes MS
J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
Imre G; Gekeler V; Leja A; Beckers T; Boehm M
Cancer Res; 2006 May; 66(10):5409-18. PubMed ID: 16707469
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.
Shetty S; Graham BA; Brown JG; Hu X; Vegh-Yarema N; Harding G; Paul JT; Gibson SB
Mol Cell Biol; 2005 Jul; 25(13):5404-16. PubMed ID: 15964798
[TBL] [Abstract][Full Text] [Related]
19. The RelA/p65 subunit of NF-kappaB specifically regulates cyclin D1 protein stability: implications for cell cycle withdrawal and skeletal myogenesis.
Dahlman JM; Wang J; Bakkar N; Guttridge DC
J Cell Biochem; 2009 Jan; 106(1):42-51. PubMed ID: 19016262
[TBL] [Abstract][Full Text] [Related]
20. Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth.
Liu S; Tan WY; Chen QR; Chen XP; Fu K; Zhao YY; Chen ZW
Cancer Sci; 2008 May; 99(5):952-7. PubMed ID: 18341653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
